DOW JONES22,327.48+690.70 3.19%
S&P 5002,626.65+85.18 3.35%
NASDAQ7,774.15+271.77 3.62%

B. Riley FBR Maintains Buy on Allena Pharmaceuticals, Lowers Price Target to $4

B. Riley FBR analyst Mayank Mamtani maintains Allena Pharmaceuticals (NASDAQ:ALNA) with a Buy and lowers the price target from $7 to $4.

Benzinga · 03/18/2020 10:57

B. Riley FBR analyst Mayank Mamtani maintains Allena Pharmaceuticals (NASDAQ:ALNA) with a Buy and lowers the price target from $7 to $4.